The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters

被引:33
作者
Bremholm, Lasse [1 ]
Hornum, Mads [2 ]
Andersen, Ulrik B. [3 ]
Holst, Jens Juul [4 ]
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Gastroenterol, DK-1168 Copenhagen, Denmark
[2] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-1168 Copenhagen, Denmark
[3] Univ Copenhagen, Glostrup Hosp, Dept Clin Physiol & Nucl Med, DK-1168 Copenhagen, Denmark
[4] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-1168 Copenhagen, Denmark
关键词
GLP-2; Blood flow; Cardiac; Human; BONE-RESORPTION; PREPROGLUCAGON GENE; NEONATAL PIGLETS; GLP-2; HUMANS; PROLIFERATION; EXPRESSION; SECRETION; RECEPTOR; OUTPUT;
D O I
10.1016/j.regpep.2009.11.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Glucagon-like peptide-2 (GLP-2) is known to increase mesenteric blood flow. The aim of the study was to evaluate the effect of GLP-2 on blood flow in different vascular sites, and dynamic changes in cardiac parameters. Methods: 10 healthy volunteers were given 450 nmol subcutaneous (SC) GLP-2 or isotonic saline (5 subjects) in a single blinded manner. During the following 90 min, blood flow in the superior mesenteric artery (SMA), celiac artery (CA), renal artery (RA), common carotid artery (CCA) was measured using Doppler ultrasound (US), and cardiovascular variables were measured by impedance cardiography and finger plethysmography. Plasma GLP-2 was measured at times 0, 30 and 60 min. Results: Compared to the placebo group, GLP-2 elicited a 27% decrease in the resistance index (RI) and a 269.4% increase in Time Averaged Maximal Velocity (TAMV) in the SMA (P<0.01). CA RA and CCA: There, were no significant changes in RI or TAMV in the GLP-2 or placebo group, and no change in CA diameter. Cardiac parameters: GLP-2 increased cardiac output (CO), stroke volume (SV) and heart rate (HR) compared to baseline (respectively: 15.3, 4.81 and 8.2% (P<0.001, P<0.01 and P<0.01)). The CO, SV and HR changes were not significantly different from the placebo group. Mean plasma GLP-2 serum levels in the placebo group at times 0, 30 and 60 min were 22.8, 23.4 and 23.2 pmol/l. In the GLP-2 group 20.3, 1273 and 1725 pmol/l. Conclusion: SC GLP-2 increased SMA blood flow, as previously shown, but elicited no changes in other vascular sites. CO and HR increased significantly, presumably due to the increased mesenteric blood flow. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 23 条
[1]   EXON DUPLICATION AND DIVERGENCE IN THE HUMAN PREPROGLUCAGON GENE [J].
BELL, GI ;
SANCHEZPESCADOR, R ;
LAYBOURN, PJ ;
NAJARIAN, RC .
NATURE, 1983, 304 (5924) :368-371
[2]   Modulation of specific intestinal epithelial progenitors by enteric neurons [J].
Bjerknes, M ;
Cheng, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12497-12502
[3]   Glucagon-like peptide-2 increases mesenteric blood flow in humans [J].
Bremholm, Lasse ;
Hornum, Mads ;
Henriksen, Birthe Merete ;
Larsen, Steen ;
Holst, Jens Juul .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (03) :314-319
[4]   GLP-2 rapidly activates divergent intracellular signaling pathways involved in intestinal cell survival and proliferation in neonatal piglets [J].
Burrin, Douglas G. ;
Stoll, Barbara ;
Guan, Xinfu ;
Cui, Liwei ;
Chang, Xiaoyan ;
Hadsell, Darryl .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (01) :E281-E291
[5]   Mediators of glucagon-like peptide 2-induced blood flow: Responses in different vascular sites [J].
Deniz, Mustafa ;
Bozkurt, Ayhan ;
Kurtel, Hizir .
REGULATORY PEPTIDES, 2007, 142 (1-2) :7-15
[6]   Induction of intestinal epithelial proliferation by glucagon-like peptide 2 [J].
Drucker, DJ ;
Ehrlich, P ;
Asa, SL ;
Brubaker, PL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7911-7916
[7]   Non-invasive beat-to-beat cardiac output monitoring by an improved method of transthoracic bioimpedance measurement [J].
Fortin, J. ;
Habenbacher, W. ;
Heller, A. ;
Hacker, A. ;
Gruellenberger, R. ;
Innerhofer, J. ;
Passath, H. ;
Wagner, Ch. ;
Haitchi, G. ;
Flotzinger, D. ;
Pacher, R. ;
Wach, P. .
COMPUTERS IN BIOLOGY AND MEDICINE, 2006, 36 (11) :1185-1203
[8]   GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets [J].
Guan, XF ;
Stoll, B ;
Lu, XF ;
Tappenden, KA ;
Holst, JJ ;
Hartmann, B ;
Burrin, DG .
GASTROENTEROLOGY, 2003, 125 (01) :136-147
[9]   Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 rats and mice [J].
Hartmann, B ;
Thulesen, J ;
Kissow, H ;
Thulesen, S ;
Orskov, C ;
Ropke, C ;
Poulsen, SS ;
Holst, JJ .
ENDOCRINOLOGY, 2000, 141 (11) :4013-4020
[10]   Structure, measurement, and secretion of human glucagon-like peptide-2 [J].
Hartmann, B ;
Johnsen, AH ;
Orskov, C ;
Adelhorst, K ;
Thim, L ;
Holst, JJ .
PEPTIDES, 2000, 21 (01) :73-80